Effect of Prazosin and Naltrexone on Script Induced Alcohol Craving in Veterans with Alcohol Use Disorders with and without Co-Occurring PTSD

Abstract

Background: Military personnel are at risk for developing hazardous drinking patterns post-deployment that can negatively impact their health and psychiatric stability. This phenomenon is compounded by the fact that despite recent gains in establishing effective pharmacological and behavioral treatments for alcohol use disorders (AUD), nonremittance and relapse remain major problems for those with AUDs. One individual factor that is strongly associated with continued problematic use and relapse is craving. Three different types of craving have been hypothesized, reward, relief, and obsessive, and each is postulated to be mediated by different neurological substrates. The neural networks postulated to subserve reward and relief craving receive afferents from and project to noradrenergic neurons in non-human primates and humans express 1 adrenergic receptors. Given the interplay of the noradrenergic system with craving-related brain systems, blocking 1 receptors with the noradrenergic antagonist, prazosin, theoretically has the potential to modulate reward and relief craving.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2016
Accession Number
AD1011702

Entities

People

  • Tracy Simpson

Organizations

  • Seattle Institute for Biomedical and Clinical Research

Tags

Communities of Interest

  • Human Systems

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Buildings And Structures
  • Department Of Defense
  • Deployment
  • Digestive System Processes
  • Diseases And Disorders
  • Electronic Mail
  • Human Behavior
  • Information Operations
  • Language
  • Medical Personnel
  • Military Personnel
  • Monitoring
  • National Guard
  • Neural Networks
  • Pharmaceutical Preparations

Fields of Study

  • Medicine

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Neuroscience

Technology Areas

  • AI & ML